HABP and VABP are extremely challenging infections to manage for various reasons. Here’s my take on how new recommendations and tools can help lead to early effective therapy.
Guidelines for hospital-acquired and ventilator-associated bacterial pneumonia are great, but you have to bring it back to the individual.
The problem with antibiograms is that they capture essentially the first specimen from a patient, and flora change with time and treatment.
Working closely with frontline ICU pharmacists and physicians is vital to obtaining microbiological histories, recent antimicrobial exposures, and drug allergies to optimize therapy on an individual level.